Evigrade

Essential phospholipids

Liver therapy (local classification)

ATC code: A05BA-ESSENTIALE

Updated · Methodology

Marketing claims without evidence base

The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.

D

Alcoholic liver disease

Not recommended

Essential phospholipids (soybean-derived) are promoted as a hepatoprotector to restore liver cells, including in alcoholic liver disease. No convincing benefit has been shown for this indication: good-quality RCTs and systematic reviews do not confirm any effect on disease course or outcomes. What helps in alcohol-related liver disease is, above all, stopping alcohol, along with correcting nutrition and deficiencies; in severe cases a doctor decides on additional treatment per guidelines. The substance itself is harmless in this role, but it should not be taken instead of an approach with proven benefit, since that delays treatment that actually works.

ICD-10: K70 · ICD-11: DB94

D

Body detoxification and cleansing

Not recommended

Essential phospholipids (sold as Essentiale, Essliver) are cell-membrane components often marketed for "detox" and "cleansing the body" of toxins. Studies have not shown a clear benefit for this use: the liver and kidneys clear the body on their own, and "toxins" or "slag" is not a concept evidence-based medicine works with. If you are worried about your liver, the answer is not a cleanse but finding the actual cause with a doctor, whether that is alcohol, excess weight or viral hepatitis.

D

Non-alcoholic fatty liver disease

Not recommended

Essential phospholipids are cell-membrane components marketed as a way to "restore" the liver in non-alcoholic fatty liver disease. They have not shown convincing benefit for this condition, and there is no solid evidence base for such use. What actually helps is weight loss, dietary changes and physical activity, plus control of blood sugar and lipids under medical supervision when those are affected. The substance itself is harmless in this role, but it should not be taken instead of approaches with proven benefit, or you risk missing the treatment you need.

ICD-10: K76.0 · ICD-11: DB92

How to read tiers A–F
  • AStrong evidence – first or second line in international guidelines
  • BRecommended in selected cases
  • CStudy data contradict each other
  • DBenefit not proven, no documented harm
  • FDocumented harm, or risk without benefit

Mechanism of action

The manufacturer claims restoration of hepatocyte cell membranes and normalization of lipid and protein metabolism in the liver. Active components are phosphatidylcholine and related phospholipids derived from soy. International liver disease guidelines (, ) do not mention essential phospholipids as a therapy with proven efficacy.

Safety

Contraindications

  • Hypersensitivity to phosphatidylcholine, soy oil, or other components
  • Antiphospholipid syndrome (injectable form)

Serious adverse effects

  • Independent data on serious adverse events are essentially absent

Common adverse effects

  • Per label — gastric discomfort, rarely diarrhea
  • Allergic skin reactions

Pregnancy: can you take Essential phospholipids?

No international recommendations on use in pregnancy.

Breastfeeding: can you take Essential phospholipids?

Doctors in Russia and Eastern Europe prescribe essential phospholipids (Essentiale) for chronic hepatitis and steatohepatitis. The product has no AEMPS registration. Cochrane reviews do not confirm clinical benefit in hepatitis. The preparation contains phosphatidylcholine and looks plausibly safe by composition, but no randomised data exist on transfer into human milk or efficacy during breastfeeding. AEMPS does not back its use as a hepatoprotector in nursing mothers.

Reference information, not a clinical decision. Discuss feeding pauses or changes with your physician or an IBCLC.

Practical notes

Russian practice note

Essential phospholipids are among the top-selling drug groups in Russia and CIS countries. The broader 'hepatoprotector' category also includes silymarin (Karsil), ademetionine (Heptral), glycyrrhizic acid with phospholipids (Phosphogliv), and thioctic acid (Thioctacid). No convincing international evidence base exists for any of these groups showing clinical efficacy in NAFLD, alcoholic liver disease, or toxic hepatitis as either primary or adjuvant therapy.

Common myths

Myth: 'hepatoprotectors shield the liver from any harmful factor'. Fact: universal 'protectors' of the liver do not exist. The only truly effective strategy is to eliminate the causative factor (alcohol, toxin, hepatotropic virus, offending drug).

Myth: 'you need liver infusions after antibiotics or chemotherapy'. Fact: routine 'hepatoprotection' in patients with normal liver tests is not indicated. In drug-induced liver injury (for example, from antituberculosis drugs), management relies on discontinuing or adjusting the offending agent.

Check interaction with another drug

Opens the checker prefilled with this drug. Pick the second one from your regimen.

Open checker

Summary of a multi-drug list →

Medicine list: everything you take in one place →

Frequently asked

What is Essential phospholipids used for?

Essential phospholipids is evaluated for the following indications with varying evidence strength: Body detoxification and cleansing (evidence tier D), Non-alcoholic fatty liver disease (evidence tier D), Alcoholic liver disease (evidence tier D). See the full indication matrix with dosing and citations above on this page.

What are the side effects of Essential phospholipids?

Common side effects of Essential phospholipids (≥ 1 in 100): Per label — gastric discomfort, rarely diarrhea, Allergic skin reactions. See the Safety section for uncommon and serious reactions.

Is Essential phospholipids safe during pregnancy?

No international recommendations on use in pregnancy.

Is Essential phospholipids compatible with breastfeeding?

Doctors in Russia and Eastern Europe prescribe essential phospholipids (Essentiale) for chronic hepatitis and steatohepatitis. The product has no AEMPS registration. Cochrane reviews do not confirm clinical benefit in hepatitis. The preparation contains phosphatidylcholine and looks plausibly safe by composition, but no randomised data exist on transfer into human milk or efficacy during breastfeeding. AEMPS does not back its use as a hepatoprotector in nursing mothers.

Can you drink alcohol while taking Essential phospholipids?

No convincing international evidence base exists for any of these groups showing clinical efficacy in NAFLD, alcoholic liver disease, or toxic hepatitis as either primary or adjuvant therapy. The only truly effective strategy is to eliminate the causative factor (alcohol, toxin, hepatotropic virus, offending drug).

Who should not take Essential phospholipids?

Essential phospholipids is contraindicated in: Hypersensitivity to phosphatidylcholine, soy oil, or other components; Antiphospholipid syndrome (injectable form). Full list in the Safety section.

hepatoprotectors shield the liver from any harmful factor

universal 'protectors' of the liver do not exist. The only truly effective strategy is to eliminate the causative factor (alcohol, toxin, hepatotropic virus, offending drug).

you need liver infusions after antibiotics or chemotherapy

routine 'hepatoprotection' in patients with normal liver tests is not indicated. In drug-induced liver injury (for example, from antituberculosis drugs), management relies on discontinuing or adjusting the offending agent.

Official sources

Direct links to regulator labels. Open in a new tab.

Other drugs in this group

Glycyrrhizic acid + phospholipids, L-ornithine-L-aspartate (LOLA), Silymarin (Silybum marianum), Tauroursodeoxycholic acid (TUDCA), Ursodeoxycholic acid